SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+48.43%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$1.2B
AUM Growth
+$1.2B
(+51%)
Cap. Flow
-$13.6M
Cap. Flow
% of AUM
-1.13%
Top 10 Holdings %
Top 10 Hldgs %
99.85%
Holding
14
New
1
Increased
3
Reduced
1
Closed
1
Top Buys
| 1 |
Alkermes
ALKS
|
$77.6M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$30.1M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$2.72M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$1.12M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$110M |
| 2 |
Puma Biotechnology
PBYI
|
$15.3M |
Sector Composition
| 1 | Healthcare | 64.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
1
DELISTED
Medicines Co
MDCO
| $357M | 29.63% | 4,202,000 | – | – |
|
2
Biogen
BIIB
$19.4B
| $191M | 15.84% | 643,000 | – | – |
|
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $137M | 11.39% | 10,307,000 +204,000 | +2% | +$2.72M |
|
|
ICPT
4
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $107M | 8.85% | 860,000 +9,000 | +1% | +$1.12M |
|
|
AGN
5
DELISTED
Allergan plc
AGN
| $89.4M | 7.42% | 467,500 -575,000 | -55% | -$110M |
|
6
Innoviva
INVA
$1.29B
| $88.4M | 7.34% | 6,242,000 | – | – |
|
|
7
Alkermes
ALKS
$4.78B
| $77.6M | 6.44% | +3,805,000 | New | +$77.6M |
|
|
8
Jazz Pharmaceuticals
JAZZ
$7.75B
| $66.2M | 5.5% | 443,500 +201,500 | +83% | +$30.1M |
|
9
Mersana Therapeutics
MRSN
$36.5M
| $21.5M | 1.78% | 3,750,000 | – | – |
|
|
RGLS
10
DELISTED
Regulus Therapeutics
RGLS
| $1.65M | 0.14% | 1,851,851 | – | – |
|
|
MRTX
11
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $128K | 0.01% | 1,000 | – | – |
|
12
AbbVie
ABBV
$372B
| $88K | 0.01% | 1,000 | – | – |
|
|
13
Puma Biotechnology
PBYI
$254M
| – | – | -1,417,000 | Closed | -$15.3M |
|